Estimation of vaccination coverage and associated factors in older Mexican adults.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
14 08 2023
Historique:
medline: 15 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

National vaccination programmes recommend the influenza vaccine for older adults, but this population group has the greatest morbidity and mortality from other preventable vaccine diseases. The aim of this article is to estimate the vaccine coverage in adults aged 65 years and older and to analyse the factors that could increase or decrease vaccination uptake probability for the three listed vaccines in the national vaccination programme (influenza, tetanus and diphtheria, and pneumococcus) and the full scheme in Mexico. We conducted an analytical cross-sectional study with 2012, 2018, and 2021 rounds from the National Health and Nutrition Survey, in which we calculated the vaccine coverage estimations and performed multivariable logistic regression models to analyse the factors related to vaccine uptake. Tetanus and diphtheria vaccines had the greatest coverage estimation in all years (59-71%), whereas the pneumococcus vaccine had the lowest (32-53%). Full scheme vaccine coverage decreased from 37.80% to 24.77% in 2012 and 2021, respectively. The National Health Card property, morbidity, being a beneficiary of any health system institution, and use of preventive services increased the probability of vaccine uptake. In conclusion, vaccine coverage in older Mexican adults decreased over time, and the Mexican health system plays a strategic role in immunisation.

Identifiants

pubmed: 37577972
doi: 10.1017/S0950268823001218
pii: S0950268823001218
pmc: PMC10468813
doi:

Substances chimiques

Influenza Vaccines 0
Tetanus Toxoid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e134

Références

Aging Clin Exp Res. 2020 Aug;32(8):1405-1415
pubmed: 32572796
J Infect Public Health. 2020 Feb;13(2):211-215
pubmed: 31431425
J Am Geriatr Soc. 2006 Feb;54(2):217-23
pubmed: 16460371
Vaccine. 2021 Jun 11;39(26):3520-3527
pubmed: 34023136
Perspect Clin Res. 2017 Jul-Sep;8(3):148-151
pubmed: 28828311
Salud Publica Mex. 2021 Nov 05;63(6, Nov-Dic):813-818
pubmed: 35099889
Gac Med Mex. 2017 Mar;153(Suppl 1):5
pubmed: 28448486
Vaccine. 2020 Dec 14;38(52):8264-8272
pubmed: 33229108
Salud Publica Mex. 2014 May-Jun;56(3):279-85
pubmed: 25272180
PLoS Med. 2017 Apr 4;14(4):e1002255
pubmed: 28376084
Kidney Int Rep. 2018 Jun 20;3(5):1171-1182
pubmed: 30197984
BMC Health Serv Res. 2014 Apr 23;14:186
pubmed: 24758691
Vaccines (Basel). 2022 Nov 17;10(11):
pubmed: 36423039
Salud Publica Mex. 2012 Jan-Feb;54(1):39-46
pubmed: 22286827
PLoS One. 2020 Dec 11;15(12):e0243833
pubmed: 33306744
Salud Publica Mex. 2006 Sep-Oct;48(5):379-84
pubmed: 17063821
Vaccine. 2021 Jan 29;39(5):846-852
pubmed: 33390294
Vaccine. 2018 Feb 8;36(7):921-931
pubmed: 29336923
Vaccine. 2016 Dec 20;34(52):6681-6690
pubmed: 27876197
Clin Geriatr Med. 2018 Feb;34(1):131-143
pubmed: 29129213
Aging Clin Exp Res. 2019 Mar;31(3):339-344
pubmed: 30859460
Vaccine. 2003 Jan 30;21(7-8):596-600
pubmed: 12531324
Salud Publica Mex. 2013;55 Suppl 2:S300-6
pubmed: 24626708
Matern Child Health J. 2009 Jul;13(4):550-8
pubmed: 18607704
BMC Int Health Hum Rights. 2013 Jul 08;13:30
pubmed: 23835202
Vaccine. 2016 Feb 17;34(8):1018-24
pubmed: 26672676

Auteurs

Héctor García-Hernández (H)

Researcher, Health Research Division, National Institute of Geriatrics, Mexico City, Mexico.

Judith Zárate-Ramírez (J)

Research Fellow, Health Reserch Division, National Institute of Geriatrics, Mexico City, Mexico.

Ashuin Kammar-García (A)

Researcher, Health Research Division, National Institute of Geriatrics, Mexico City, Mexico.

Carmen García-Peña (C)

General Director, National Institute of Geriatrics, Mexico City, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH